Peripheral
SFA

Back to the future in lower limb PAD

What does the future hold for lower-limb PAD management? 

This PVI 2025 session looks at how personalised antithrombotic therapy, medico-administrative data and artificial intelligence could shape the next steps in PAD care. 

From tailoring treatment to harnessing real-world data and exploring the potential of AI, discover the tools and approaches set to influence the future of lower-limb PAD!

Koen Deloose
Koen Deloose
Dendermonde, Belgium
Hospital: AZ Sint Blasius
Anahita Dua
Anahita Dua
Boston, United States
Yann Gouëffic
Yann Gouëffic
Hospital: Paris Saint-Joseph, France

Professor of Vascular Surgery 
President of the association of the french university hospitals for clinical research 

Conflicts of interest:

Research funding from Predisurge, Biotronik, WL Gore, GE Healthcare 
Honoraria from Abbott, BD, Bentely, Biotronik, Boston Scientific, Cook, Eclevar Medtech, GE Healthcare, Ivascular, Medtronic, Penumbra, Sensome, Shockwave medical, WL Gore (consulting, medical advisory board, educational course, speaking)

Trisha Roy
Trisha Roy
Houston, United States
Eric Secemsky
Eric Secemsky
Boston, United States

You must be logged in or create an account to see all the content